Invention Grant
- Patent Title: Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activation
-
Application No.: US16246398Application Date: 2019-01-11
-
Publication No.: US10435434B2Publication Date: 2019-10-08
- Inventor: Sumayah Jamal
- Applicant: ENB Therapeutics, Inc.
- Applicant Address: US NY New York
- Assignee: ENB THERAPEUTICS, INC.
- Current Assignee: ENB THERAPEUTICS, INC.
- Current Assignee Address: US NY New York
- Agency: Wilson Sonsini Goodrich & Rosati, P.C.
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07K5/02 ; C07B59/00 ; A61K38/17 ; A61P35/00
Abstract:
Disclosed herein are deuterated compounds, pharmaceutical compositions thereof, and methods for treating ETBR-related cancers. Also disclosed herein is a delivery system for the controlled, systemic release of at least one deuterated ETBR antagonist, optionally in conjunction with an additional anti-oncologic agent.
Public/Granted literature
- US20190218251A1 DEUTERATED COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING CANCERS ASSOCIATED WITH ETBR ACTIVATION Public/Granted day:2019-07-18
Information query
IPC分类:
